Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Element Eight

start up
United States - Los Angeles, California
  • 08/11/2023
  • Unknown
  • $6,000,000

Skincare, formulated with OATH™, a proprietary complex of topically applied oxygen carriers that mimic the function of hemoglobin in the blood. OATH™ holds 20x more oxygen than water and delivers it directly to your skin cells, dramatically improving the skin’s regenerative processes and restoring optimal skin barrier health.

OXYGEN AMPLIFIED THERAPY
OATH™ was developed for spine surgery to mimic the function of hemoglobin in the blood and deliver oxygen directly to oxygen deprived surgical sites. A scientific breakthrough that had significant healing properties and increased healing times by 5x, Element Eight scientists encapsulated the carrier technology for use in skincare.

Oxygen depletion in the skin is one of the leading causes of the signs of aging. Sixty percent of the skin’s oxygen levels are lost by the age of 40. Our proprietary oxygen delivery system carries 20x more molecular oxygen than water and releases it deep into your skin cells.


Related People

Gerard CammeFounder

Gerard Camme United States - New York, New York

Entrepreneurial executive with more than 30 years of experience in beauty working on brands such as Atelier Cologne and Fresh with the mission of developing strategic growth plans. Currently starting from scratch with Element Eight, a skincare bran that fits perfectly into the most dynamic segment of the skincare market...big on science, luxury with a very unique point of difference. Element Eight will disrupt this segment that outperforms the category year after year.